Literature DB >> 22410391

Suprapubic appendectomy: a different single-incision approach.

Jesús Ángel Garijo Álvarez1, Martín Gascón Hove, Tomás González Elosua.   

Abstract

INTRODUCTION: Appendectomy is performed on almost 700 000 patients per year in the European Community, rendering it the most common acute surgical procedure. Since the introduction of laparoscopic surgery, there has been increased interest in carrying out procedures with fewer incisions and less ports.
MATERIALS AND METHODS: After the inception of single-port access, it is possible to insert into the abdominal cavity multiple instruments through a single device. A total of 15 patients--mean age 22 years and mean body mass index 27 kg/m(2)--with acute appendicitis were included in this study.
RESULTS: Mean operative time was 35 minutes with no conversions. Local suction drain was needed in 2 patients. Mean hospital stay was less than 24 hours with no complications.
CONCLUSION: Single-port suprapubic appendectomy is feasible and safe, and can allow a more direct vision of the operating field depending on the position of the appendix and presents good cosmetic and postoperative outcomes.

Entities:  

Keywords:  laparoendoscopic single-site surgery (LESS); laparoscopic appendectomy; single-incision laparoscopic surgery (SILS); single-port access; suprapubic LESS appendectomy

Mesh:

Year:  2012        PMID: 22410391     DOI: 10.1177/1553350612438973

Source DB:  PubMed          Journal:  Surg Innov        ISSN: 1553-3506            Impact factor:   2.058


  2 in total

1.  Single-port access surgery resection of a presacral schwannoma.

Authors:  M Gascón Hove; A Pueyo Rabanal; M Cea Soriano; P Galindo Jara; J A Garijo Álvarez
Journal:  Tech Coloproctol       Date:  2013-01-23       Impact factor: 3.781

2.  Conventional three-port laparoscopic appendectomy versus transumbilical and suprapubic single-incision laparoscopic appendectomy using only conventional laparoscopic instruments.

Authors:  Shaohan Wu; Yiyu Shen; Jing Wang; Jinquan Wei; Xujian Chen
Journal:  Langenbecks Arch Surg       Date:  2022-09-20       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.